Summary by Moomoo AI
Omar Jimenez, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that no securities are beneficially owned by Jimenez. The form, signed on March 11, 2024, is a standard disclosure for individuals in significant positions within publicly traded companies, and it is used to report any direct or indirect ownership of the company's securities. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.